News

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...
Want to lose weight and reverse type 2 diabetes? Trade diet soda for a tall glass of water, a new small-scale study argues.
CHICAGO — Actor, comedian and diabetes advocate Anthony Anderson has lived with diabetes for almost 25 years, and has made ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.
will present four peer-reviewed posters at the American Diabetes Association’s (ADA) 85th Scientific Sessions, which will take place June 20–23 in Chicago. These latest poster presentations ...